Daniel Hochhauser
- Oncology top 0.5%
- PARP inhibition in cancer therapy 19
- Pancreatic and Hepatic Oncology Research 18
- Colorectal Cancer Treatments and Studies 16
- Cancer-related Molecular Pathways 11
- Cancer Research top 1%
- Hepatology top 2%
-
- Gastric Cancer Management and Outcomes 16
- Lung Cancer Treatments and Mutations 12
- Molecular Biology top 2%
- Cancer therapeutics and mechanisms 34
- DNA Repair Mechanisms 18
- Co-authors
- John A. HartleyDirk ArnoldAdrian L. HarrisEric Van CutsemMichele ReniHedy L. KindlerTalia GolanGershon Y. Locker
- Cited by
- OncologyCancer ResearchHepatology
- Journals
- Journal of Clinical Oncology (21 papers)Annals of Oncology (10 papers)British Journal of Cancer (10 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Daniel Hochhauser
142 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Oncology 4.5k
- Cancer Research 1.5k
- Hepatology 346
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 2.7k
Countries citing papers authored by Daniel Hochhauser
This map shows the geographic impact of Daniel Hochhauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Hochhauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Hochhauser more than expected).
Fields of papers citing papers by Daniel Hochhauser
This network shows the impact of papers produced by Daniel Hochhauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Hochhauser. The network helps show where Daniel Hochhauser may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Hochhauser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2022 | 120 | |
| 3 | 2020 | 19 | |
| 4 | Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upbreakdown → | 2020 | 736 |
| 5 | 2019 | 33 | |
| 6 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancerbreakdown → | 2019 | 1468 |
| 7 | 2019 | 33 | |
| 8 | Ten year follow up case control study of the effect of portal vein embolization (PVE) on the survival of patients with colorectal liver metastases (CRLM) and the influence of hypoxia factors on tumour growth | 2016 | 3 |
| 9 | 2015 | 47 | |
| 10 | 2015 | 178 | |
| 11 | 2015 | 36 | |
| 12 | 2015 | 3 | |
| 13 | 2014 | 26 | |
| 14 | 2013 | 9 | |
| 15 | 2012 | 50 | |
| 16 | 2011 | 233 | |
| 17 | 2007 | 16 | |
| 18 | Targetted treatment of disseminated NETs with radiopeptides | 2000 | 1 |
| 19 | Phase II study of irinotecan and high dose infusional 5- fluorouracil (5-FU) and folinic acid for first and second line treatment of advanced colorectal cancer | 2000 | 0 |
| 20 | 1986 | 33 |
About Daniel Hochhauser
Daniel Hochhauser is a scholar working on Oncology, Toxicology, Cancer Research, Hepatology and Pulmonary and Respiratory Medicine, having authored 153 papers that have together received 7.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (34 papers), PARP inhibition in cancer therapy (19 papers), DNA Repair Mechanisms (18 papers), Pancreatic and Hepatic Oncology Research (18 papers), Gastric Cancer Management and Outcomes (16 papers), Colorectal Cancer Treatments and Studies (16 papers), Lung Cancer Treatments and Mutations (12 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Oncology (4.5k citations), Cancer Research (1.5k citations), Hepatology (346 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Molecular Biology (2.7k citations). Daniel Hochhauser has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include John A. Hartley, Dirk Arnold, Adrian L. Harris, Eric Van Cutsem, Michele Reni, Hedy L. Kindler, Talia Golan, Gershon Y. Locker, David McGuinness and Teresa Macarulla. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, The Lancet and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.